Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
A Multicenter Prospective Diagnostic Test: Screening and Differentiating Common Cancers (Cancers of Lung, Stomach, Colorectum, Esophagus, Liver, Breast and Pancreas) Based on Peripheral Blood Cell-Free DNA Sequencing
Sponsor: Air Force Military Medical University, China
Listed as NCT06036563, this observational or N/A phase trial focuses on Breast Cancer and Cancer Diagnosis and remains actively recruiting participants. Sponsored by Air Force Military Medical University, China, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2023 — Jun 2024 [monthly]
Not Yet Recruiting
First recorded
Sep 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Air Force Military Medical University, China
- First Hospital of China Medical University
- Guanxian People's Hospital
- People's Hospital of Ningxia Hui Autonomous Region
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Tang-Du Hospital
- The First Affiliated Hospital of Guangzhou Medical University
- Xinjiang Medical University
For direct contact, visit the study record on ClinicalTrials.gov .